FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Nemaura Medical Set to Join the Russell 2000® Index and Russell 3000® Index.”
Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor (“CGM”), together with BEAT®diabetes, a planned health subscription service designed to help people with Type 2 diabetes and prediabetes through personalized lifestyle coaching, today announced the Company is set to join the small cap Russell 2000® Index and the broad-market Russell 3000® Index at the conclusion of this year’s reconstitution of the Russell stock indexes, effective after the U.S. stock market opens on Monday, June 29, 2020, according to a preliminary list of additions posted June 5, 2020.
“Inclusion in the Russell Indexes is an important milestone and will increase the overall awareness and exposure of our stock within the investment community,” stated Dr. Faz Chowdhury, CEO of Nemaura. “Broader exposure to the investment community comes at an ideal time for Nemaura as we move forward with product sales in the coming months and quarters.”
Nemaura Medical, Inc. (NMRD), is a medical technology company commercializing BEAT®diabetes, a health subscription service designed to help people with diabetes and prediabetes better manage diabetes and reverse Type 2 diabetes or prevent diabetes through 1-on-1 lifestyle coaching and behavior driven by real time continuous glucose monitoring (CGM) and daily glucose trend data provided by sugarBEAT®, a non-invasive and flexible CGM.
Medical devices range from simple tongue depressors and bedpans to complex programmable pacemakers and closed loop artificial pancreas systems. In addition, in vitro diagnostic (IVD) products, such as reagents, test kits, and blood glucose meters as well as certain radiation-emitting electronic products that have a medical use or make medical claims are also considered medical devices. It is an industry that has traditionally depended on technological innovation and often complex healthcare infrastructure. For example, medical device manufacturers are now focusing on improving sensor technologies as well as the accuracy of data. Furthermore, the highly anticipated 5G network development is expected to help portability and miniaturization of electronics, enabling the design of more reliable and adaptable technologies. Geographically, the United States remains the largest medical device market in the world, with USD 156 Billion and represented 40% of the global medical device market in 2017. And by 2023, it is expected to grow to USD 208 Billion, according to data provided by SelectUSA Services.
In recent years, werable devices have also become part of the industry. There is a wide range of wearables, including many used for medical purposes. According to Healthcare Information and Management Systems Society, Inc. (HIMSS), wearable technologies can be innovative solutions for healthcare problems, enable the continuous monitoring of human physical activities and behaviors, as well as physiological and biochemical parameters during daily life. The most commonly measured data include vital signs such as heart rate, blood pressure, and body temperature, as well as blood oxygen saturation, posture, and physical activities through the use of electrocardiogram (ECG), ballistocardiogram (BCG) and other devices. Wearable devices are usually designed to communicate with other devices, such as smartphones, which are typically used to collect information and transmit it to a remote server for storage and analysis.
For more information, please visit: Nemaura Medical, Inc.
For more corporate news on Nemaura Medical, Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.